Phase 2 Peripheral Arterial Disease Trial, Recruiting NCT05371145 Sponsor: Shahid Baba Condition: Peripheral Arterial Disease
Back to Peripheral Arterial Disease

Phase 2 Peripheral Arterial Disease Trial, Recruiting

NCT05371145
Recruiting Phase 2

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are a man between 51 and 79 years old
  • You identify as White or African American
  • You speak English
  • You have a specific measurement of blood flow in your legs that falls in a certain low range (called an ABI of 0.4 to below 0.60 — confirm with trial site what this means for you)
  • You are willing to follow all the requirements of the study
  • You are able to understand and sign a consent form agreeing to take part

Who may not be able to join:

  • You have HIV, hepatitis, significant liver disease, an active infection, anemia, an organ transplant, kidney disease requiring dialysis, a lung condition requiring oxygen, a significant heart defect present from birth, any type of cancer, or an untreated thyroid condition
  • You have been diagnosed with a rare condition called carnosinemia (a metabolic disorder — confirm with trial site)
  • You have a known allergy to L-carnosine or meat
  • You have a pacemaker
  • You have obesity caused by a known genetic condition
  • You have dementia
  • You have severely reduced blood flow to a limb and have had an amputation below or above the knee
  • You have foot ulcers (open sores on your feet)
  • You have had a major amputation
  • You are currently taking part in another clinical trial
  • You have end-stage kidney disease
  • You have had a significant injury within the past 30 days
  • You are currently a prisoner
  • You have any metal implants in your body
  • You have poorly controlled diabetes, based on a blood sugar measurement called HbA1c being above 9%

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 2
Sponsor
Shahid Baba
Registry
ClinicalTrials.gov
Start date
1 March 2023
Est. completion
30 December 2024

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Carnosine for Peripheral Arterial Disease patients

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov